Photoredox-catalyzed deuteration and tritiation of pharmaceutical compounds.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 29123019.
- Also identified by DOI 10.1126/science.aap9674 and PMC identifier 5907472.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Deuterium- and tritium-labeled pharmaceutical compounds are pivotal diagnostic tools in drug discovery research, providing vital information about the biological fate of drugs and drug metabolites. Herein we demonstrate that a photoredox-mediated hydrogen atom transfer protocol can efficiently and selectively install deuterium (D) and tritium (T) at α-amino sp<sup>3</sup> carbon-hydrogen bonds in a single step, using isotopically labeled water (D<sub>2</sub>O or T<sub>2</sub>O) as the source of hydrogen isotope. In this context, we also report a convenient synthesis of T<sub>2</sub>O from T<sub>2</sub>, providing access to high-specific-activity T<sub>2</sub>O. This protocol has been successfully applied to the high incorporation of deuterium and tritium in 18 drug molecules, which meet the requirements for use in ligand-binding assays and absorption, distribution, metabolism, and excretion studies.
Medical subject headings
- Deuterium
- Pharmaceutical Preparations
- Tritium